- Ginkgo Bioworks to Participate in Two Conferences in May
- Sojitz Corporation and Ginkgo Bioworks Announce Plans to Use Synthetic Biology R&D Services to Accelerate Sustainable Manufacturing in Japan
- Ginkgo Bioworks Receives Continued Listing Standard Notice From NYSE
- Ginkgo Bioworks Reports First Quarter 2024 Financial Results
- GreenLab Partners with Ginkgo Bioworks to Scale Up Production of Brazzein, a Novel Sweetener
- Ginkgo Bioworks Announces Presentations at the Upcoming American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
- Ginkgo Bioworks Announces Date of First Quarter 2024 Results Presentation
- Ginkgo Bioworks Announces Nomination of Myrtle Potter and Ross Fubini to Board of Directors
- Il Granaio delle Idee and Ginkgo Bioworks Announce Strategic Collaboration to Optimize Sourdough Strains for Bakery Products
- Ginkgo Bioworks Announces Acquisition of AgBiome's Platform Assets
More ▼
Key statistics
On Friday, Ginkgo Bioworks Holdings Inc (DNA:NYQ) closed at 0.5285, 4.65% above its 52-week low of 0.505, set on May 31, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.5593 |
---|---|
High | 0.5663 |
Low | 0.505 |
Bid | 0.5351 |
Offer | 0.5573 |
Previous close | 0.5285 |
Average volume | 53.03m |
---|---|
Shares outstanding | 2.21bn |
Free float | 1.59bn |
P/E (TTM) | -- |
Market cap | 1.17bn USD |
EPS (TTM) | -0.4347 USD |
Data delayed at least 15 minutes, as of May 31 2024 21:10 BST.
More ▼